Curative Labs Inc

1700 Royston Ln, Suite B

Round Rock, TX 78664
support@curative.com
Final Results
Report

Patient Name: DARNELL, JANETTE Facility: Texas Curative Testing

Patient MRN: CUR164540043 Requisition: 59338485

Date of Birth: 06/29/1960 (62 years old) Kit ID: A396084511855

Sex: FEMALE Collected: 07/28/2022 10:38:15 AM CDT

234 KENDRICK PINES BLVD

Address: Received: 07/28/2022 11:50:32 PM CDT
SPRING, TX 77389

Phone Number: (346) 495-5616 Released: 07/29/2022 01:22:04 PM CDT

Email: jeanettedarnell9@gmail.com Specimen Type: Alinity shallow nasal swab

Physician: Zalzala, Sajad

(1639311509)

Test Result

SARS-CoV-2 Assay (RNA Detection Test by RT-PCR) Indeterminate

Interpretation:

Positive: SARS-CoV-2 RNA detected by RT-PCR

Negative: SARS-CoV-2 RNA not detected by RT-PCR
Indeterminate: Indeterminate for SARS-CoV-2 RNA by RT-PCR.

Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical

correlation with patient history and other diagnostic information is
necessary
to determine patient infection status. Positive results do not
rule out bacterial infection or co-infection with other viruses. The agent
detected may not be
the definite cause of disease. Laboratories within the
United States and its territories are required to report all positive
results to the appropriate public
health authorities.

Negative results do not preclude SARS-CoV-2 infection and should not be used
as the sole basis for patient management decisions. Inadequate sample
collection or exposure to extreme heat during transport may decrease the
ability to detect SARS-CoV-2 RNA in a sample. Negative results must be
combined with clinical observations, patient history, and epidemiological
information.

Indeterminate results means that the test was not able to clearly determine
whether SARS-CoV-2 was or was not present and may occur in the case of an
inadequate specimen. Specimen must be recollected if test is still required.

Method: Curative HT SARS-CoV-2 Test (Real-Time

Reverse-Transcription PCR)

This test is based on the CDC SARS-CoV-2 assay, a real-time

reverse-transcription polymerase chain reaction (RT-PCR) test that detects
RNA from
SARS-CoV-2 in upper or lower respiratory specimens. The test has
been optimized to be performed on the BioRad CFX Real-Time PCR detection
system
and uses high throughput technologies.

Disclaimer:

This SARS-CoV-2 PCR test was developed and its performance characteristics
were determined by Curative Labs. This test has not been cleared,
approved
or authorized by the U.S. Food and Drug Administration (FDA). This test may
be used for clinical purposes and should not be regarded as
investigational
or for research only. Curative Laboratory is certified under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA) as qualified to
perform
high complexity clinical laboratory testing. The results are not intended to
be used as the sole means for clinical diagnosis or patient management
decisions.

Lab director: Arthur Baca MD, PhD; CLIA #

45D2192800; Sample reviewed at: 07/29/2022 12:52:04 PM CDT; Report generated at:
07/31/2022 05:23:38
PM CDT